Development of biomimetic materials for Alzheimer's disease

被引:0
|
作者
Patel, D
机构
[1] Univ Maryland Baltimore Cty, Baltimore, MD 21250 USA
[2] Texas A&M Univ, Dept Chem Engn, College Stn, TX 77843 USA
关键词
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
421-BIOT
引用
收藏
页码:U246 / U246
页数:1
相关论文
共 50 条
  • [21] Development of a drug candidate for Alzheimer's disease
    Pham, Johnny
    Campagna, Jesus
    Spilman, Patricia
    Alam, Mohammad Parvez
    Jagodzinska, Barbara
    Bredesen, Dale
    Jung, Michael
    John, Varghese
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 251
  • [22] Advances in Alzheimer's Disease Drug Development
    Rafii, Michael S.
    Aisen, Paul S.
    BMC MEDICINE, 2015, 13
  • [23] Drug discovery and development for Alzheimer's disease
    Lyketsos, CG
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2002, 10 (06): : 756 - 756
  • [24] Development of capillary dysfunction in Alzheimer's disease
    Vorobev, S.
    Yanishevskiy, S.
    Efimtsev, S.
    Sokolov, A.
    Dyachuk, V.
    FRONTIERS IN AGING NEUROSCIENCE, 2024, 16
  • [25] Learning slows the development of Alzheimer's disease
    不详
    FUTURE NEUROLOGY, 2007, 2 (02) : 141 - 141
  • [26] New Drug Development in Alzheimer's Disease
    Apter, Jeffrey
    Liebowitz, Michael
    NEUROPSYCHOPHARMACOLOGY, 2023, 48 : 296 - 296
  • [27] Alzheimer's disease: treatments in discovery and development
    Citron, M
    NATURE NEUROSCIENCE, 2002, 5 (Suppl 11) : 1055 - 1057
  • [28] The effect of insomnia on development of Alzheimer’s disease
    Shaghayegh Sadeghmousavi
    Mahsa Eskian
    Farzaneh Rahmani
    Nima Rezaei
    Journal of Neuroinflammation, 17
  • [29] Alzheimer's disease: treatments in discovery and development
    Martin Citron
    Nature Neuroscience, 2002, 5 : 1055 - 1057
  • [30] Controversies in Alzheimer's disease drug development
    Cummings, Jeffrey L.
    INTERNATIONAL REVIEW OF PSYCHIATRY, 2008, 20 (04) : 389 - 395